Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome

NCT05638633 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

321

Enrollment

OTHER

Sponsor class

Conditions

Post-COVID-19 Syndrome

Interventions

DRUG: Prednisolone 20 mg/ 5 mg
DRUG: Vitamin B compound (100mg B1, 50 mg B6, 500 µg B12)
DRUG: Placebo for Vitamin B compound
DRUG: Placebo for Prednisolon

Sponsor

Wuerzburg University Hospital

Collaborators

[object Object]
[object Object]